Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kelman

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Annals of Internal Medicine|November 18, 2024
The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial EmulationSteven T Bird, Kate Gelperin, Elizabeth R Smith, et al.
JAMA|January 19, 2024
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent PatientsSteven T Bird, Elizabeth R Smith, Kate Gelperin, et al.
American Journal of Epidemiology|May 9, 2013
Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010Laura L Polakowski, Sukhminder K Sandhu, David B Martin, et al.
JAMA Oncology|December 20, 2019
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare BeneficiariesSteven T Bird, Fang Tian, Natasha Flowers, et al.
Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.
The American Journal of Medicine|July 16, 2023
Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare BeneficiariesDavid J Graham, Hector S Izurieta, Di Zhang, et al.
Critical Care Medicine|February 15, 2020
Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012-2018Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, et al.
Critical Care Medicine|February 15, 2020
Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012-2018Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, et al.
Critical Care Medicine|September 28, 2021
Sepsis Among Medicare Beneficiaries: 4. Precoronavirus Disease 2019 Update January 2012-February 2020Charles E Frank, Timothy G Buchman, Steven Q Simpson, et al.
Critical Care Medicine|February 15, 2020
Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012-2018Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Annals of Internal Medicine|November 18, 2024
The Effect of Denosumab on Risk for Emergently Treated Hypocalcemia by Stage of Chronic Kidney Disease : A Target Trial EmulationSteven T Bird, Kate Gelperin, Elizabeth R Smith, et al.
JAMA|January 19, 2024
Severe Hypocalcemia With Denosumab Among Older Female Dialysis-Dependent PatientsSteven T Bird, Elizabeth R Smith, Kate Gelperin, et al.
American Journal of Epidemiology|May 9, 2013
Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010Laura L Polakowski, Sukhminder K Sandhu, David B Martin, et al.
JAMA Oncology|December 20, 2019
Idelalisib for Treatment of Relapsed Follicular Lymphoma and Chronic Lymphocytic Leukemia: A Comparison of Treatment Outcomes in Clinical Trial Participants vs Medicare BeneficiariesSteven T Bird, Fang Tian, Natasha Flowers, et al.
Journal of General Internal Medicine|October 2, 2021
Risk of Covid-19-Related Hospitalization and More Severe Outcomes in Medicare Beneficiaries Treated with Renin-Angiotensin-Aldosterone System Inhibitors for HypertensionDavid J Graham, Hector S Izurieta, Stella G Muthuri, et al.
The American Journal of Medicine|July 16, 2023
Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare BeneficiariesDavid J Graham, Hector S Izurieta, Di Zhang, et al.
Critical Care Medicine|February 15, 2020
Sepsis Among Medicare Beneficiaries: 3. The Methods, Models, and Forecasts of Sepsis, 2012-2018Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, et al.
Critical Care Medicine|February 15, 2020
Sepsis Among Medicare Beneficiaries: 2. The Trajectories of Sepsis, 2012-2018Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, et al.
Critical Care Medicine|September 28, 2021
Sepsis Among Medicare Beneficiaries: 4. Precoronavirus Disease 2019 Update January 2012-February 2020Charles E Frank, Timothy G Buchman, Steven Q Simpson, et al.
Critical Care Medicine|February 15, 2020
Sepsis Among Medicare Beneficiaries: 1. The Burdens of Sepsis, 2012-2018Timothy G Buchman, Steven Q Simpson, Kimberly L Sciarretta, et al.
Pageof 11